|
Match
|
Document |
Document Title |
|
|
6977087 |
Aerodynamically light particles for pulmonary drug delivery
Improved aerodynamically light particles for delivery to the pulmonary system, and methods for their preparation and administration are provided. In a preferred embodiment, the aerodynamically...
|
|
|
6960350 |
Antifungal fragrance composition
An antifungal fragrance composition containing as its active ingredients: (a) at least one type of fragrance component selected from the group consisting of an aliphatic or aromatic aldehyde having...
|
|
|
6946120 |
Pharmaceutical composition
A pharmaceutical composition for topical administration, including, as the pharmaceutically active component, at least 5% by weight, based on the total weight of the composition of a...
|
|
|
6939534 |
Method to treat pulmonary hypoplasia in the newborn
A method of treating pulmonary hypoplasia in infants has been developed, wherein epidermal growth factor (EGF) is administered to the pulmonary system of an infant in need of treatment thereof. The...
|
|
|
6936272 |
10139483Therapeutic liposome composition and method of preparation
A fusogenic liposome composition for delivering a liposome-entrapped compound into the cytoplasm of a target cell is described. The liposomes have an outer surface coating of chemically releasable...
|
|
|
6932964 |
Cosmetic composition with water-soluble or water-dispersible polymers
A cosmetic composition comprising at least one water-soluble or water-dispersible polymer which comprises, in copolymerized form,
a) at least one α,β-ethylenically unsaturated monomer of...
|
|
|
6913805 |
Controlled release ampule containing a fumigant
The present invention provides an apparatus and method for controlled release of a fumigant into a wooden structure to prevent decay of that structure. According to the present invention, a...
|
|
|
6861458 |
Photoprotective and lightfastness-enhancing siloxanes
Disclosed is a compound of one of the formulae
wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 each, independently of the others, is an alkyl group, an aryl group, an...
|
|
|
6838075 |
Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
The present invention provides highly dispersible spray-dried powder compositions, and in particular, inhaleable dry powder compositions for aerosolized delivery to the lungs. The powders of the...
|
|
|
6830744 |
Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
Stable aqueous formulations which are free of products derived from human or animal origin and which maintain high biological activity and high chemical and physical stability of alpha-type...
|
|
|
6818204 |
Stable foam for use in disposable wipe
An aqueous stable foam, suitable for use as a vaginal or hemorrhoidal wipe agent, containing at least one surfactant and at least one foam stabilizing agent can be dispensed to bathroom tissue or...
|
|
|
6811793 |
Effervescent composition including stevia
A tablet that includes stevia, water soluble binder, water soluble lubricant, active agent, and effervescent agent.
|
|
|
6803047 |
Vaporizable gelled composition
A topical composition containing an aqueous gel which contains a hydrophilic gelling material, wherein the gel has at least one of the following properties: an initial viscosity V 0 ranging from...
|
|
|
6803031 |
Delivery of erectile dysfunction drugs through an inhalation route
The present invention relates to the delivery of erectile dysfunction drugs through an inhalation route. Specifically, it relates to aerosols containing erectile dysfunction drugs that are used in...
|
|
|
6797281 |
Esters of I-carnitine or alkanoyl I-carnitines
Esters of L-carnitine and alkanoyl L-carnitines are described which can be used as cationic lipids for the intracellular delivery of pharmacologically active compounds. New esters of L-carnitine...
|
|
|
6776989 |
Intratracheal administration of lysozyme
The subject invention is directed to the treatment of respiratory disorders by intratracheal administration of an effective amount of lysozyme. Respiratory disorders include emphysema, pneumonia,...
|
|
|
6774151 |
Method of producing an absorbent foam material
A method of producing a porous, liquid absorbent, open-cell polymeric foam material having properties which makes it suitable for use as an absorbent structure in absorbent articles such as...
|
|
|
6770262 |
Nasal administration of agents for the treatment of gastroparesis
The present invention is directed to a method for the treatment of gastroparesis by the use of metoclopramide nasal formulation.
|
|
|
6767925 |
Sprayable analgesic composition and method of use
A sprayable analgesic composition containing an analgesic which is absorbed into the bloodstream through the buccal mucosa and a pharmacologically acceptable liquid carrier.
|
|
|
6761903 |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present...
|
|
|
6761909 |
Particulate insulin-containing products and method of manufacture
Provided is a compressed anti-solvent technique for manufacture of insulin-containing powders for pulmonary delivery. The insulin is processed in a cosolvent system including two or more mutually...
|
|
|
6747058 |
Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
A formulation of delta-9-tetrahydrocannabinol in a semi-aqueous solvent, such as 35:10:55 alcohol:water:propylene glycol (v/v), produces a stable clear solution near the solubility point of the...
|
|
|
6743413 |
Suspension aerosol formulations
Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134 a , HFC 227, or a mixture thereof.
|
|
|
6740307 |
Delivery of β-blockers through an inhalation route
The present invention relates to the delivery of beta-blockers through an inhalation route. Specifically, it relates to aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol...
|
|
|
6716884 |
Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
A pharmaceutical composition for the administration of phloroglucinol includes phloroglucinol in combination with a buffer system capable of buffering the composition when placed in an aqueous...
|
|
|
6713047 |
Pharmaceutical aerosol composition containing HFA 227 and HFA 134a
In a solution composition for use in an aerosol inhaler which comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility compound the use...
|
|
|
6706255 |
Liquid pharmaceutical compositions comprising thyroid hormones
Liquid pharmaceutical compositions comprising at least one thyroid hormone, ethanol, a pH adjusting agent, and water are disclosed. The compositions may be delivered by a metered dosage delivery...
|
|
|
6706344 |
Controlled fumigation of wooden structures
The present invention provides an apparatus and method for controlled release of a fumigant into a wooden structure to prevent decay of that structure. According to the present invention, a...
|
|
|
6703010 |
Spray containing amphoteric material to reduce malodors
Powder compositions usable to reduce malodours, and powder formulations from which can be made aqueous spray compositions usable to reduce malodours, each comprise, as a major ingredient,...
|
|
|
6689339 |
Viscous compositions containing carbon dioxide
A carbon dioxide-containing viscous composition wherein carbon dioxide bubbles are retained in an aqueous viscous composition. Use of the composition makes it possible to treat or ameliorate...
|
|
|
6685926 |
Method and composition adjusted to the isoelectric point of hair for conditioning of oxidatively dyed hair
A method of conditioning and oxidatively dyeing human hair includes applying an oxidative hair dyeing composition to the human hair in order to dye the human hair and, simultaneously or...
|
|
|
6682726 |
Self-foaming shaving lotion
The present invention is directed to a self-foaming shaving composition in the form of a lotion. The shaving composition comprises water, a water dispersible surface active agent capable of forming...
|
|
|
6669960 |
Particulate drug-containing products and method of manufacture
Provided is a compressed anti-solvent technique for manufacture of drug-containing powders for pulmonary delivery. The drug is processed in a cosolvent system including two or more mutually soluble...
|
|
|
6660288 |
Insect repellents
The use of specific perfume ingredients, e.g. tricyclodecenyl allyl ether, to repel insects. The perfume ingredients may be used in a composition comprising from 0.1 to 40 percent by weight of one...
|
|
|
6638495 |
Stabilized preparation for use in metered dose inhalers
Stabilized dispersions are provided for the delivery of a bioactive agent to the respiratory tract of a patient. The dispersions preferably comprise a plurality of perforated microstructures...
|
|
|
6632419 |
Increasing libido in humans via acute testosterone administration
The libido of adult human female patients is increased by the bolus delivery of a testosterone which is preferably dihydrotestosterone. The formulation is preferably aerosolized and inhaled into a...
|
|
|
6630466 |
Medicament compositions containing anticholinergically-effective compounds and salmeterol
The present invention relates to new medicament compositions based on anticholinergic compounds, which have a long-lasting effect, and salmeterol, processes for their production and their use in...
|
|
|
6623753 |
Allylamine-containing liposomes
The invention concerns liposomal preparations comprising as the active agent a compound of formula I in free base form or in acid addition salt form. It also concerns a method of preparation of...
|
|
|
6613307 |
Aerosol formulations of salmeterol xinafoate
The present invention relates to formulations comprising particulate products which may be prepared by methods and apparatus using supercritical fluids. More particularly, the invention relates to...
|
|
|
6610271 |
System and method for intranasal administration of lorazepam
A therapeutic composition of lorazepam and its pharmaceutically acceptable derivatives are provided for intranasal administration of at least one predetermined volumetric unit dose in the form of a...
|
|
|
6608073 |
Intranasal codeine for the rapid suppression of cough and rapid relief of pain
This invention provides a method of rapidly and reliably delivering codeine, alone or in combination with other compounds, to the systemic circulation by administration via the nasal route to...
|
|
|
6605304 |
Silicate-containing powders providing controlled, sustained gas release
A particle including anions dispersed throughout an amorohous, paracrystalline or crystalline solid solution, the anions being capable of reacting with hydronioum ions to generated a gas. The...
|
|
|
6596740 |
Nicotine mucosal spray
A composition for administration to the nasal mucosa of a subject comprises a solution of nicotine or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable solvent. The...
|
|
|
6596261 |
Method of administering a medicinal aerosol formulation
A method of treating in a human or animal a condition capable of treatment by oral or nasal inhalation has been found. The method comprises administering a medicinal aerosol formulation comprising...
|
|
|
6585957 |
Medicinal aerosol formulation
A medicinal formulation is disclosed. The formulation comprises (a) a protein or peptide medicament; (b) a fluid carrier for containing said medicament; and a stabilizer selected from an amino...
|
|
|
6585984 |
Dual composition cosmetic product with a concentration sensitive and an incompatible active respectively placed within first and second compositions
A cosmetic product is provided packaged in a dispenser with separate first and second storage areas. The first of the areas contains a first cosmetic composition containing a first dermal active...
|
|
|
6582729 |
Powered pharmaceutical formulations having improved dispersibility
Dispersibility of a respirable powder, administrable by inhalation, is increased by including a pharmaceutically acceptable water-soluble polypeptide.
|
|
|
6579512 |
Topical steroid spray
A pharmaceutical topical spray composition of corticosteroid, an alcohol, a propelant, and isopropyl myristate. A method for treating an inflammatory skin condition using the administration to the...
|
|
|
6576810 |
Toilet training article containing an effervescent agent
A toilet training article in the form of a toilet training pad containing an effervescent agent is disclosed. The toilet training pad, which may be an insertable pad or integrated directly into an...
|
|
|
6565885 |
Methods of spray drying pharmaceutical compositions
Spray drying methods for forming powder compositions for pharmaceutical applications are disclosed. According to one aspect of the invention, the spray drying feed stock comprises a bioactive...
|